ID
13072
Description
Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00154739
Link
https://clinicaltrials.gov/show/NCT00154739
Keywords
Versions (1)
- 1/14/16 1/14/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 14, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Small Cell Lung Cancer NCT00154739
Eligibility Non-Small Cell Lung Cancer NCT00154739
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
cns metastases, concomitant myelosuppressive radiotherapy, c/t, hormonal therapy or immunotherapy.
Data type
boolean
Alias
- UMLS CUI [1]
- C0686377
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0279025
- UMLS CUI [4]
- C0021083
Description
cardiac disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00154739
- StudyEvent: Eligibility
C0948762 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0002594 (UMLS CUI [4])
C1522449 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0021083 (UMLS CUI [4])